{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:14:03Z","timestamp":1790741643263,"version":"4.1.0"},"reference-count":284,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1038\/s41582-019-0294-x","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T19:02:45Z","timestamp":1578078165000},"page":"84-96","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":194,"title":["Sex differences in movement disorders"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2995-6762","authenticated-orcid":false,"given":"Sara","family":"Meoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Macerollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7968-5908","authenticated-orcid":false,"given":"Elena","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"294_CR1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","volume":"14","author":"MT Ferretti","year":"2018","unstructured":"Ferretti, M. T. et al. Sex differences in Alzheimer disease \u2014 the gateway to precision medicine. Nat. Rev. Neurol. 14, 457\u2013469 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"294_CR2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrneurol.2017.95","volume":"13","author":"C Cordonnier","year":"2017","unstructured":"Cordonnier, C. et al. Stroke in women \u2014 from evidence to inequalities. Nat. Rev. Neurol. 13, 521\u2013532 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"294_CR3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1474-4422(16)30293-9","volume":"16","author":"KG Vetvik","year":"2017","unstructured":"Vetvik, K. G. & MacGregor, E. A. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol. 16, 76\u201387 (2017).","journal-title":"Lancet Neurol."},{"key":"294_CR4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/mds.25723","volume":"29","author":"ML Rabin","year":"2014","unstructured":"Rabin, M. L., Stevens-Haas, C., Havrilla, E., Devi, T. & Kurlan, R. Movement disorders in women: a review. Mov. Disord. 29, 177\u2013183 (2014).","journal-title":"Mov. Disord."},{"key":"294_CR5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2014.03.010","volume":"259","author":"KM Smith","year":"2014","unstructured":"Smith, K. M. & Dahodwala, N. Sex differences in Parkinson\u2019s disease and other movement disorders. Exp. Neurol. 259, 44\u201356 (2014).","journal-title":"Exp. Neurol."},{"key":"294_CR6","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00415-016-8384-9","volume":"264","author":"M Picillo","year":"2017","unstructured":"Picillo, M. et al. The relevance of gender in Parkinson\u2019s disease: a review. J. Neurol. 264, 1583\u20131607 (2017).","journal-title":"J. Neurol."},{"key":"294_CR7","doi-asserted-by":"crossref","unstructured":"Fahn, S. & Jankovic, J. Principles and Practice of Movement Disorders (Churchill Livingstone, 2007).","DOI":"10.1016\/B978-0-443-07941-2.50029-2"},{"key":"294_CR8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.nbd.2007.02.009","volume":"26","author":"I Cantuti-Castelvetri","year":"2007","unstructured":"Cantuti-Castelvetri, I. et al. Effects of gender on nigral gene expression and parkinson disease. Neurobiol. Dis. 26, 606\u2013614 (2007).","journal-title":"Neurobiol. Dis."},{"key":"294_CR9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008856","volume":"5","author":"F Simunovic","year":"2010","unstructured":"Simunovic, F., Yi, M., Wang, Y., Stephens, R. & Sonntag, K. C. Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease. PLOS ONE 5, e8856 (2010).","journal-title":"PLOS ONE"},{"key":"294_CR10","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/hbm.21283","volume":"33","author":"M Rijpkema","year":"2012","unstructured":"Rijpkema, M. et al. Normal sexual dimorphism in the human basal ganglia. Hum. Brain Mapp. 33, 1246\u20131252 (2012).","journal-title":"Hum. Brain Mapp."},{"key":"294_CR11","first-page":"112","volume":"21","author":"J Xu","year":"2000","unstructured":"Xu, J. et al. Gender effects on age-related changes in brain structure. Am. J. Neuroradiol. 21, 112\u2013118 (2000).","journal-title":"Am. J. Neuroradiol."},{"key":"294_CR12","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.yfrne.2014.02.002","volume":"35","author":"GE Gillies","year":"2014","unstructured":"Gillies, G. E., Pienaar, I. S., Vohra, S. & Qamhawi, Z. Sex differences in Parkinson\u2019s disease. Front. Neuroendocrinol. 35, 370\u2013384 (2014).","journal-title":"Front. Neuroendocrinol."},{"key":"294_CR13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neubiorev.2015.09.024","volume":"67","author":"N Litim","year":"2016","unstructured":"Litim, N., Morissette, M. & Di Paolo, T. Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson\u2019s disease. Neurosci. Biobehav. Rev. 67, 79\u201388 (2016).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"294_CR14","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/ene.12450","volume":"21","author":"N Greene","year":"2014","unstructured":"Greene, N., Lassen, C. F., Rugbjerg, K. & Ritz, B. Reproductive factors and Parkinson\u2019s disease risk in Danish women. Eur. J. Neurol. 21, 1168\u20131177 (2014).","journal-title":"Eur. J. Neurol."},{"key":"294_CR15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/mds.25771","volume":"29","author":"R Liu","year":"2014","unstructured":"Liu, R. et al. Female reproductive factors, menopausal hormone use, and Parkinson\u2019s disease. Mov. Disord. 29, 889\u2013896 (2014).","journal-title":"Mov. Disord."},{"key":"294_CR16","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.parkreldis.2014.08.003","volume":"20","author":"NM Gatto","year":"2014","unstructured":"Gatto, N. M. et al. Lifetime exposure to estrogens and Parkinson\u2019s disease in California teachers. Parkinsonism Relat. Disord. 20, 1149\u20131156 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3389\/fneur.2018.00701","volume":"9","author":"C Strafella","year":"2018","unstructured":"Strafella, C. et al. Application of precision medicine in neurodegenerative diseases. Front. Neurol. 9, 701 (2018).","journal-title":"Front. Neurol."},{"key":"294_CR18","unstructured":"Institute of Medicine (eds Wizemann, T. M. & Pardue. M.-L.). Exploring the Biological Contributions to Human Health: Does Sex Matter? (National Academies Press, 2001)."},{"key":"294_CR19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert, M., Spillantini, M. G., Del Tredici, K. & Braak, H. 100 years of Lewy pathology. Nat. Rev. Neurol. 9, 13\u201324 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"294_CR20","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson, D. W. et al. Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol. 8, 1150\u20131157 (2009).","journal-title":"Lancet Neurol."},{"key":"294_CR21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/mds.24996","volume":"27","author":"RB Postuma","year":"2012","unstructured":"Postuma, R. B. et al. Identifying prodromal Parkinson\u2019s disease: pre-motor disorders in Parkinson\u2019s disease. Mov. Disord. 27, 617\u2013626 (2012).","journal-title":"Mov. Disord."},{"key":"294_CR22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1532-5415.2012.03909.x","volume":"60","author":"KL Moore","year":"2012","unstructured":"Moore, K. L., Boscardin, W. J., Steinman, M. A. & Schwartz, J. B. Age and sex variation in prevalence of chronic medical conditions in older residents of US nursing homes. J. Am. Geriatr. Soc. 60, 756\u2013764 (2012).","journal-title":"J. Am. Geriatr. Soc."},{"key":"294_CR23","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim, T., Jette, N., Frolkis, A. & Steeves, T. D. L. The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov. Disord. 29, 1583\u20131590 (2014).","journal-title":"Mov. Disord."},{"key":"294_CR24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mdc3.12568","volume":"5","author":"MM Abbas","year":"2018","unstructured":"Abbas, M. M., Xu, Z. & Tan, L. C. S. Epidemiology of Parkinson\u2019s disease \u2014 East versus West. Mov. Disord. Clin. Pract. 5, 14\u201328 (2018).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"294_CR25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/ane.12201","volume":"129","author":"J Xu","year":"2014","unstructured":"Xu, J., Gong, D. D., Man, C. F. & Fan, Y. Parkinson\u2019s disease and risk of mortality: meta-analysis and systematic review. Acta Neurol. Scand. 129, 71\u201379 (2014).","journal-title":"Acta Neurol. Scand."},{"key":"294_CR26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.parkreldis.2017.02.024","volume":"38","author":"T Maeda","year":"2017","unstructured":"Maeda, T. et al. Clinical manifestations of nonmotor symptoms in 1021 Japanese Parkinson\u2019s disease patients from 35 medical centers. Parkinsonism Relat. Disord. 38, 54\u201360 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR27","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/jnnp-2015-312283","volume":"87","author":"F Moisan","year":"2016","unstructured":"Moisan, F. et al. Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis. J. Neurol. Neurosurg. Psychiatry 87, 952\u2013957 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"294_CR28","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.parkreldis.2014.02.030","volume":"20","author":"LML de Lau","year":"2014","unstructured":"de Lau, L. M. L., Verbaan, D., Marinus, J. & van Hilten, J. J. Survival in Parkinson\u2019s disease. Relation with motor and non-motor features. Parkinsonism Relat. Disord. 20, 613\u2013616 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/mds.26060","volume":"30","author":"B Pinter","year":"2015","unstructured":"Pinter, B. et al. Mortality in Parkinson\u2019s disease: a 38-year follow-up study. Mov. Disord. 30, 266\u2013269 (2015).","journal-title":"Mov. Disord."},{"key":"294_CR30","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/jnnp.2006.104695","volume":"78","author":"KSM Taylor","year":"2007","unstructured":"Taylor, K. S. M., Cook, J. A. & Counsell, C. E. Heterogeneity in male to female risk for Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 78, 905\u2013906 (2007).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"294_CR31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp.2003.020982","volume":"75","author":"GF Wooten","year":"2004","unstructured":"Wooten, G. F., Currie, L. J., Bovbjerg, V. E., Lee, J. K. & Patrie, J. Are men at greater risk for Parkinson\u2019s disease than women? J. Neurol. Neurosurg. Psychiatry 75, 637\u2013639 (2004).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"294_CR32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000445751","volume":"46","author":"L Hirsch","year":"2016","unstructured":"Hirsch, L., Jette, N., Frolkis, A., Steeves, T. & Pringsheim, T. The incidence of Parkinson\u2019s disease: a systematic review and meta-analysis. Neuroepidemiology 46, 292\u2013300 (2016).","journal-title":"Neuroepidemiology"},{"key":"294_CR33","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio, A. & Schwarzschild, M. A. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 15, 1257\u20131272 (2016).","journal-title":"Lancet Neurol."},{"key":"294_CR34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"GBD 2016 Neurology Collaborators","year":"2019","unstructured":"GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden Of Disease Study 2016. Lancet Neurol. 18, 459\u2013480 (2019).","journal-title":"Lancet Neurol."},{"key":"294_CR35","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/mds.22414","volume":"24","author":"A Diem-Zangerl","year":"2009","unstructured":"Diem-Zangerl, A. et al. Mortality in Parkinson\u2019s disease: a 20-year follow-up study. Mov. Disord. 24, 819\u2013825 (2009).","journal-title":"Mov. Disord."},{"key":"294_CR36","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","volume":"78","author":"CA Haaxma","year":"2007","unstructured":"Haaxma, C. A. et al. Gender differences in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 78, 819\u2013824 (2007).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"294_CR37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/jnnp.2008.168211","volume":"80","author":"G Alves","year":"2009","unstructured":"Alves, G. et al. Incidence of Parkinson\u2019s disease in Norway: the Norwegian ParkWest study. J. Neurol. Neurosurg. Psychiatry 80, 851\u2013857 (2009).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"294_CR38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mds.10305","volume":"18","author":"D Twelves","year":"2003","unstructured":"Twelves, D., Perkins, K. S. M. & Counsell, C. Systematic review of incidence studies of Parkinson\u2019s disease. Mov. Disord. 18, 19\u201331 (2003).","journal-title":"Mov. Disord."},{"key":"294_CR39","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/brain\/awn323","volume":"132","author":"F Simunovic","year":"2009","unstructured":"Simunovic, F. et al. Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson\u2019s disease pathology. Brain J. Neurol. 132, 1795\u20131809 (2009).","journal-title":"Brain J. Neurol."},{"key":"294_CR40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3346\/jkms.2000.15.3.327","volume":"15","author":"YH Bae","year":"2000","unstructured":"Bae, Y. H., Hwang, J. Y., Kim, Y. H. & Koh, J. Y. Anti-oxidative neuroprotection by estrogens in mouse cortical cultures. J. Korean Med. Sci. 15, 327\u2013336 (2000).","journal-title":"J. Korean Med. Sci."},{"key":"294_CR41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1385\/ENDO:21:1:77","volume":"21","author":"H Sawada","year":"2003","unstructured":"Sawada, H. & Shimohama, S. Estrogens and Parkinson disease: novel approach for neuroprotection. Endocrine 21, 77\u201379 (2003).","journal-title":"Endocrine"},{"key":"294_CR42","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/mds.1170","volume":"16","author":"MD Benedetti","year":"2001","unstructured":"Benedetti, M. D. et al. Hysterectomy, menopause, and estrogen use preceding Parkinson\u2019s disease: an exploratory case\u2013control study. Mov. Disord. 16, 830\u2013837 (2001).","journal-title":"Mov. Disord."},{"key":"294_CR43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1212\/01.wnl.0000171344.87802.94","volume":"65","author":"RA Popat","year":"2005","unstructured":"Popat, R. A. et al. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease. Neurology 65, 383\u2013390 (2005).","journal-title":"Neurology"},{"key":"294_CR44","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1212\/01.WNL.0000046523.05125.87","volume":"60","author":"A Ascherio","year":"2003","unstructured":"Ascherio, A. et al. Caffeine, postmenopausal estrogen, and risk of Parkinson\u2019s disease. Neurology 60, 790\u2013795 (2003).","journal-title":"Neurology"},{"key":"294_CR45","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1002\/mds.23951","volume":"26","author":"A Nicoletti","year":"2011","unstructured":"Nicoletti, A. et al. Reproductive factors and Parkinson\u2019s disease: a multicenter case-control study. Mov. Disord. 26, 2563\u20132566 (2011).","journal-title":"Mov. Disord."},{"issue":"Suppl. 2","key":"294_CR46","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1007\/s100720200082","volume":"23","author":"E Martignoni","year":"2002","unstructured":"Martignoni, E. et al. Parkinson\u2019s disease and reproductive life events. Neurol. Sci. 23 (Suppl. 2), S85\u2013S86 (2002).","journal-title":"Neurol. Sci."},{"key":"294_CR47","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archneur.61.6.886","volume":"61","author":"LJ Currie","year":"2004","unstructured":"Currie, L. J., Harrison, M. B., Trugman, J. M., Bennett, J. P. & Wooten, G. F. Postmenopausal estrogen use affects risk for Parkinson disease. Arch. Neurol. 61, 886\u2013888 (2004).","journal-title":"Arch. Neurol."},{"key":"294_CR48","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1212\/WNL.62.11.2010","volume":"62","author":"P Ragonese","year":"2004","unstructured":"Ragonese, P. et al. Risk of Parkinson disease in women: effect of reproductive characteristics. Neurology 62, 2010\u20132014 (2004).","journal-title":"Neurology"},{"key":"294_CR49","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1212\/01.wnl.0000280573.30975.6a","volume":"70","author":"WA Rocca","year":"2008","unstructured":"Rocca, W. A. et al. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 70, 200\u2013209 (2008).","journal-title":"Neurology"},{"key":"294_CR50","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/mds.22619","volume":"24","author":"KC Simon","year":"2009","unstructured":"Simon, K. C., Chen, H., Gao, X., Schwarzschild, M. A. & Ascherio, A. Reproductive factors, exogenous estrogen use, and risk of Parkinson\u2019s disease. Mov. Disord. 24, 1359\u20131365 (2009).","journal-title":"Mov. Disord."},{"key":"294_CR51","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/mds.21341","volume":"22","author":"R Frigerio","year":"2007","unstructured":"Frigerio, R. et al. Number of children and risk of Parkinson\u2019s disease. Mov. Disord. 22, 632\u2013639 (2007).","journal-title":"Mov. Disord."},{"key":"294_CR52","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.parkreldis.2013.01.008","volume":"19","author":"K Rugbjerg","year":"2013","unstructured":"Rugbjerg, K., Christensen, J., Tjonneland, A. & Olsen, J. H. Exposure to estrogen and women\u2019s risk for Parkinson\u2019s disease: a prospective cohort study in Denmark. Parkinsonism Relat. Disord. 19, 457\u2013460 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR53","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.parkreldis.2013.07.020","volume":"19","author":"E Cereda","year":"2013","unstructured":"Cereda, E., Barichella, M., Cassani, E., Caccialanza, R. & Pezzoli, G. Reproductive factors and clinical features of Parkinson\u2019s disease. Parkinsonism Relat. Disord. 19, 1094\u20131099 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR54","first-page":"59","volume":"11","author":"P Wang","year":"2015","unstructured":"Wang, P., Li, J., Qiu, S., Wen, H. & Du, J. Hormone replacement therapy and Parkinson\u2019s disease risk in women: a meta-analysis of 14 observational studies. Neuropsychiatr. Dis. Treat. 11, 59\u201366 (2015).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"294_CR55","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/mds.25076","volume":"27","author":"N Palacios","year":"2012","unstructured":"Palacios, N. et al. Caffeine and risk of Parkinson\u2019s disease in a large cohort of men and women. Mov. Disord. 27, 1276\u20131282 (2012).","journal-title":"Mov. Disord."},{"key":"294_CR56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbr.2017.07.025","volume":"335","author":"M Lv","year":"2017","unstructured":"Lv, M. et al. Reproductive factors and risk of Parkinson\u2019s disease in women: a meta-analysis of observational studies. Behav. Brain Res. 335, 103\u2013110 (2017).","journal-title":"Behav. Brain Res."},{"key":"294_CR57","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yhbeh.2012.05.013","volume":"63","author":"R Savica","year":"2013","unstructured":"Savica, R., Grossardt, B. R., Bower, J. H., Ahlskog, J. E. & Rocca, W. A. Risk factors for Parkinson\u2019s disease may differ in men and women: an exploratory study. Horm. Behav. 63, 308\u2013314 (2013).","journal-title":"Horm. Behav."},{"key":"294_CR58","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/mdc3.12545","volume":"4","author":"LM Chahine","year":"2017","unstructured":"Chahine, L. M. & Stern, M. B. Parkinson\u2019s disease biomarkers: where are we and where do we go next? Mov. Disord. Clin. Pract. 4, 796\u2013805 (2017).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"294_CR59","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000323265","volume":"8","author":"K Ikeda","year":"2011","unstructured":"Ikeda, K. et al. Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson\u2019s disease: changes linked to disease progression. Neurodegener. Dis. 8, 252\u2013258 (2011).","journal-title":"Neurodegener. Dis."},{"key":"294_CR60","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00702-013-0972-6","volume":"120","author":"G Caranci","year":"2013","unstructured":"Caranci, G. et al. Gender differences in Parkinson\u2019s disease: focus on plasma \u03b1-synuclein. J. Neural Transm. 120, 1209\u20131215 (2013).","journal-title":"J. Neural Transm."},{"key":"294_CR61","first-page":"704678","volume":"2014","author":"DH Ho","year":"2014","unstructured":"Ho, D. H., Yi, S., Seo, H., Son, I. & Seol, W. Increased DJ-1 in urine exosome of Korean males with Parkinson\u2019s disease. Biomed. Res. Int. 2014, 704678 (2014).","journal-title":"Biomed. Res. Int."},{"key":"294_CR62","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/aje\/kwp033","volume":"169","author":"H Chen","year":"2009","unstructured":"Chen, H., Mosley, T. H., Alonso, A. & Huang, X. Plasma urate and Parkinson\u2019s disease in the Atherosclerosis Risk in Communities (ARIC) study. Am. J. Epidemiol. 169, 1064\u20131069 (2009).","journal-title":"Am. J. Epidemiol."},{"key":"294_CR63","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1212\/WNL.0000000000002351","volume":"86","author":"X Gao","year":"2016","unstructured":"Gao, X., O\u2019Reilly, E. J., Schwarzschild, M. A. & Ascherio, A. Prospective study of plasma urate and risk of Parkinson disease in men and women. Neurology 86, 520\u2013526 (2016).","journal-title":"Neurology"},{"key":"294_CR64","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/archneur.2008.65.6.nct70003","volume":"65","author":"MA Schwarzschild","year":"2008","unstructured":"Schwarzschild, M. A. et al. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch. Neurol. 65, 716\u2013723 (2008).","journal-title":"Arch. Neurol."},{"key":"294_CR65","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archneurol.2009.247","volume":"66","author":"A Ascherio","year":"2009","unstructured":"Ascherio, A. et al. Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch. Neurol. 66, 1460\u20131468 (2009).","journal-title":"Arch. Neurol."},{"key":"294_CR66","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/mds.23741","volume":"26","author":"MA Schwarzschild","year":"2011","unstructured":"Schwarzschild, M. A. et al. Serum urate and probability of dopaminergic deficit in early \u2018Parkinson\u2019s disease\u2019. Mov. Disord. 26, 1864\u20131868 (2011).","journal-title":"Mov. Disord."},{"key":"294_CR67","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1468-1331.2012.03745.x","volume":"20","author":"S Jesus","year":"2013","unstructured":"Jesus, S. et al. Low serum uric acid concentration in Parkinson\u2019s disease in southern Spain. Eur. J. Neurol. 20, 208\u2013210 (2013).","journal-title":"Eur. J. Neurol."},{"key":"294_CR68","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000346370","volume":"12","author":"NR McFarland","year":"2013","unstructured":"McFarland, N. R., Burdett, T., Desjardins, C. A., Frosch, M. P. & Schwarzschild, M. A. Postmortem brain levels of urate and precursors in Parkinson\u2019s disease and related disorders. Neurodegener. Dis. 12, 189\u2013198 (2013).","journal-title":"Neurodegener. Dis."},{"key":"294_CR69","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1007\/s00415-016-8265-2","volume":"263","author":"SK Yadav","year":"2016","unstructured":"Yadav, S. K. et al. Gender-based analysis of cortical thickness and structural connectivity in Parkinson\u2019s disease. J. Neurol. 263, 2308\u20132318 (2016).","journal-title":"J. Neurol."},{"key":"294_CR70","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/mds.27725","volume":"34","author":"R De Micco","year":"2019","unstructured":"De Micco, R. et al. Sex-related pattern of intrinsic brain connectivity in drug-naive Parkinson\u2019s disease patients. Mov. Disord. 34, 997\u20131005 (2019).","journal-title":"Mov. Disord."},{"key":"294_CR71","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.neurobiolaging.2015.01.016","volume":"36","author":"V Kaasinen","year":"2015","unstructured":"Kaasinen, V., Joutsa, J., Noponen, T., Johansson, J. & Seppanen, M. Effects of aging and gender on striatal and extrastriatal [123I]FP-CIT binding in Parkinson\u2019s disease. Neurobiol. Aging 36, 1757\u20131763 (2015).","journal-title":"Neurobiol. Aging"},{"key":"294_CR72","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/brain\/124.6.1125","volume":"124","author":"V Kaasinen","year":"2001","unstructured":"Kaasinen, V. et al. Increased frontal [18F]fluorodopa uptake in early Parkinson\u2019s disease: sex differences in the prefrontal cortex. Brain J. Neurol. 124, 1125\u20131130 (2001).","journal-title":"Brain J. Neurol."},{"key":"294_CR73","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3109\/00207454.2015.1020113","volume":"126","author":"S Mariani","year":"2016","unstructured":"Mariani, S. et al. Association between sex, systemic iron variation and probability of Parkinson\u2019s disease. Int. J. Neurosci. 126, 354\u2013360 (2016).","journal-title":"Int. J. Neurosci."},{"key":"294_CR74","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.parkreldis.2010.02.012","volume":"16","author":"N Palacios","year":"2010","unstructured":"Palacios, N. et al. Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson\u2019s disease in men and women. Parkinsonism Relat. Disord. 16, 370\u2013375 (2010).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR75","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neulet.2011.11.032","volume":"506","author":"M San Luciano","year":"2012","unstructured":"San Luciano, M. et al. Gender differences in the IL6\u00a0-174G>C and ESR2 1730G>A polymorphisms and the risk of Parkinson\u2019s disease. Neurosci. Lett. 506, 312\u2013316 (2012).","journal-title":"Neurosci. Lett."},{"key":"294_CR76","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1212\/01.wnl.0000244345.49809.36","volume":"67","author":"LN Clark","year":"2006","unstructured":"Clark, L. N. et al. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology 67, 1786\u20131791 (2006).","journal-title":"Neurology"},{"key":"294_CR77","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jamaneurol.2014.1973","volume":"72","author":"I Agalliu","year":"2015","unstructured":"Agalliu, I. et al. Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis. JAMA Neurol. 72, 58\u201365 (2015).","journal-title":"JAMA Neurol."},{"key":"294_CR78","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.parkreldis.2014.04.016","volume":"20","author":"R Cilia","year":"2014","unstructured":"Cilia, R. et al. LRRK2 mutations in Parkinson\u2019s disease: confirmation of a gender effect in the Italian population. Parkinsonism Relat. Disord. 20, 911\u2013914 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR79","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1212\/01.wnl.0000277637.33328.d8","volume":"69","author":"A Orr-Urtreger","year":"2007","unstructured":"Orr-Urtreger, A. et al. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? Neurology 69, 1595\u20131602 (2007).","journal-title":"Neurology"},{"key":"294_CR80","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neulet.2011.03.098","volume":"496","author":"R Saunders-Pullman","year":"2011","unstructured":"Saunders-Pullman, R. et al. Gender differences in the risk of familial parkinsonism: beyond LRRK2? Neurosci. Lett. 496, 125\u2013128 (2011).","journal-title":"Neurosci. Lett."},{"key":"294_CR81","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/acn3.489","volume":"4","author":"M San Luciano","year":"2017","unstructured":"San Luciano, M. et al. Sex differences in LRRK2 G2019S and idiopathic Parkinson\u2019s disease. Ann. Clin. Transl. Neurol. 4, 801\u2013810 (2017).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"294_CR82","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.parkreldis.2015.05.002","volume":"21","author":"Z Gan-Or","year":"2015","unstructured":"Gan-Or, Z. et al. LRRK2 mutations in Parkinson disease; a sex effect or lack thereof? A meta-analysis. Parkinsonism Relat. Disord. 21, 778\u2013782 (2015).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR83","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fnagi.2018.00283","volume":"10","author":"L Shu","year":"2018","unstructured":"Shu, L. et al. Clinical heterogeneity among LRRK2 variants in Parkinson\u2019s disease: a meta-analysis. Front. Aging Neurosci. 10, 283 (2018).","journal-title":"Front. Aging Neurosci."},{"key":"294_CR84","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10048-009-0198-9","volume":"11","author":"Z Gan-Or","year":"2010","unstructured":"Gan-Or, Z. et al. LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease. Neurogenetics 11, 121\u2013125 (2010).","journal-title":"Neurogenetics"},{"key":"294_CR85","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jns.2016.08.059","volume":"370","author":"M Swan","year":"2016","unstructured":"Swan, M. et al. Neuropsychiatric characteristics of GBA-associated Parkinson disease. J. Neurol. Sci. 370, 63\u201369 (2016).","journal-title":"J. Neurol. Sci."},{"key":"294_CR86","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1474-4422(15)00178-7","volume":"14","author":"MA Nalls","year":"2015","unstructured":"Nalls, M. A. et al. Diagnosis of Parkinson\u2019s disease on the basis of clinical and genetic classification: a population-based modelling study. Lancet Neurol. 14, 1002\u20131009 (2015).","journal-title":"Lancet Neurol."},{"key":"294_CR87","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s002590000279","volume":"27","author":"J Lavalaye","year":"2000","unstructured":"Lavalaye, J., Booij, J., Reneman, L., Habraken, J. B. & van Royen, E. A. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. Eur. J. Nucl. Med. 27, 867\u2013869 (2000).","journal-title":"Eur. J. Nucl. Med."},{"key":"294_CR88","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.genm.2011.05.002","volume":"8","author":"R Saunders-Pullman","year":"2011","unstructured":"Saunders-Pullman, R., Wang, C., Stanley, K. & Bressman, S. B. Diagnosis and referral delay in women with Parkinson\u2019s disease. Gend. Med. 8, 209\u2013217 (2011).","journal-title":"Gend. Med."},{"key":"294_CR89","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0277-9536(02)00458-6","volume":"57","author":"J Adamson","year":"2003","unstructured":"Adamson, J., Ben-Shlomo, Y., Chaturvedi, N. & Donovan, J. Ethnicity, socio-economic position and gender \u2014 do they affect reported health-care seeking behaviour? Soc. Sci. Med. 57, 895\u2013904 (2003).","journal-title":"Soc. Sci. Med."},{"key":"294_CR90","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S1474-4422(17)30328-9","volume":"16","author":"JC Latourelle","year":"2017","unstructured":"Latourelle, J. C. et al. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson\u2019s disease: a longitudinal cohort study and validation. Lancet Neurol. 16, 908\u2013916 (2017).","journal-title":"Lancet Neurol."},{"key":"294_CR91","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/ene.12751","volume":"23","author":"NW Scott","year":"2016","unstructured":"Scott, N. W., Macleod, A. D. & Counsell, C. E. Motor complications in an incident Parkinson\u2019s disease cohort. Eur. J. Neurol. 23, 304\u2013312 (2016).","journal-title":"Eur. J. Neurol."},{"key":"294_CR92","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/mds.20993","volume":"21","author":"K Sato","year":"2006","unstructured":"Sato, K. et al. Prognosis of Parkinson\u2019s disease: time to stage III, IV, V, and to motor fluctuations. Mov. Disord. 21, 1384\u20131395 (2006).","journal-title":"Mov. Disord."},{"key":"294_CR93","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.parkreldis.2015.11.007","volume":"22","author":"A Bjornestad","year":"2016","unstructured":"Bjornestad, A. et al. Risk and course of motor complications in a population-based incident Parkinson\u2019s disease cohort. Parkinsonism Relat. Disord. 22, 48\u201353 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR94","doi-asserted-by":"crossref","first-page":"787451","DOI":"10.1155\/2015\/787451","volume":"2015","author":"D Colombo","year":"2015","unstructured":"Colombo, D. et al. The \u201cgender factor\u201d in wearing-off among patients with Parkinson\u2019s disease: a post hoc analysis of DEEP study. Sci. World J. 2015, 787451 (2015).","journal-title":"Sci. World J."},{"key":"294_CR95","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archneur.62.4.601","volume":"62","author":"M Zappia","year":"2005","unstructured":"Zappia, M. et al. Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study. Arch. Neurol. 62, 601\u2013605 (2005).","journal-title":"Arch. Neurol."},{"key":"294_CR96","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.parkreldis.2010.06.003","volume":"16","author":"JC Sharma","year":"2010","unstructured":"Sharma, J. C., Bachmann, C. G. & Linazasoro, G. Classifying risk factors for dyskinesia in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 16, 490\u2013497 (2010).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR97","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1007\/s00415-011-6067-0","volume":"258","author":"S Hassin-Baer","year":"2011","unstructured":"Hassin-Baer, S. et al. Gender effect on time to levodopa-induced dyskinesias. J. Neurol. 258, 2048\u20132053 (2011).","journal-title":"J. Neurol."},{"key":"294_CR98","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jocn.2013.12.016","volume":"21","author":"M Lubomski","year":"2014","unstructured":"Lubomski, M., Louise Rushworth, R., Lee, W., Bertram, K. L. & Williams, D. R. Sex differences in Parkinson\u2019s disease. J. Clin. Neurosci. 21, 1503\u20131506 (2014).","journal-title":"J. Clin. Neurosci."},{"key":"294_CR99","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jamaneurol.2018.4377","volume":"76","author":"E De Pablo-Fernandez","year":"2019","unstructured":"De Pablo-Fernandez, E., Lees, A. J., Holton, J. L. & Warner, T. T. Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease. JAMA Neurol. 76, 470\u2013479 (2019).","journal-title":"JAMA Neurol."},{"key":"294_CR100","first-page":"107","volume":"91","author":"MWIM Horstink","year":"2003","unstructured":"Horstink, M. W. I. M., Strijks, E. & Dluzen, D. E. Estrogen and Parkinson\u2019s disease. Adv. Neurol. 91, 107\u2013114 (2003).","journal-title":"Adv. Neurol."},{"key":"294_CR101","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/mds.870010112","volume":"1","author":"NP Quinn","year":"1986","unstructured":"Quinn, N. P. & Marsden, C. D. Menstrual-related fluctuations in Parkinson\u2019s disease. Mov. Disord. 1, 85\u201387 (1986).","journal-title":"Mov. Disord."},{"key":"294_CR102","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/00207458908986223","volume":"45","author":"R Sandyk","year":"1989","unstructured":"Sandyk, R. Estrogens and the pathophysiology of Parkinson\u2019s disease. Int. J. Neurosci. 45, 119\u2013122 (1989).","journal-title":"Int. J. Neurosci."},{"key":"294_CR103","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1017\/S0317167100010490","volume":"37","author":"A Castrioto","year":"2010","unstructured":"Castrioto, A., Hulliger, S., Poon, Y.-Y., Lang, A. E. & Moro, E. A survey on the impact of the menstrual cycle on movement disorders severity. Can. J. Neurol. Sci. 37, 478\u2013481 (2010).","journal-title":"Can. J. Neurol. Sci."},{"key":"294_CR104","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1212\/WNL.52.7.1417","volume":"52","author":"R Saunders-Pullman","year":"1999","unstructured":"Saunders-Pullman, R. et al. The effect of estrogen replacement on early Parkinson\u2019s disease. Neurology 52, 1417\u20131421 (1999).","journal-title":"Neurology"},{"key":"294_CR105","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1212\/WNL.54.12.2292","volume":"54","author":"KL Tsang","year":"2000","unstructured":"Tsang, K. L., Ho, S. L. & Lo, S. K. Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations. Neurology 54, 2292\u20132298 (2000).","journal-title":"Neurology"},{"key":"294_CR106","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/1531-8257(200001)15:1<132::AID-MDS1020>3.0.CO;2-C","volume":"15","author":"LM Shulman","year":"2000","unstructured":"Shulman, L. M., Minagar, A. & Weiner, W. J. The effect of pregnancy in Parkinson\u2019s disease. Mov. Disord. 15, 132\u2013135 (2000).","journal-title":"Mov. Disord."},{"key":"294_CR107","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0733-8619(18)30083-5","volume":"12","author":"LI Golbe","year":"1994","unstructured":"Golbe, L. I. Pregnancy and movement disorders. Neurol. Clin. 12, 497\u2013508 (1994).","journal-title":"Neurol. Clin."},{"key":"294_CR108","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/mds.870130110","volume":"13","author":"P Hagell","year":"1998","unstructured":"Hagell, P., Odin, P. & Vinge, E. Pregnancy in Parkinson\u2019s disease: a review of the literature and a case report. Mov. Disord. 13, 34\u201338 (1998).","journal-title":"Mov. Disord."},{"key":"294_CR109","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.parkreldis.2017.05.007","volume":"40","author":"M Seier","year":"2017","unstructured":"Seier, M. & Hiller, A. Parkinson\u2019s disease and pregnancy: an updated review. Parkinsonism Relat. Disord. 40, 11\u201317 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1550-8579(07)80003-9","volume":"4","author":"LM Shulman","year":"2007","unstructured":"Shulman, L. M. Gender differences in Parkinson\u2019s disease. Gend. Med. 4, 8\u201318 (2007).","journal-title":"Gend. Med."},{"key":"294_CR111","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/bs.irn.2017.05.032","volume":"133","author":"A Sauerbier","year":"2017","unstructured":"Sauerbier, A., Lenka, A., Aris, A. & Pal, P. K. Nonmotor symptoms in Parkinson\u2019s disease: gender and ethnic differences. Int. Rev. Neurobiol. 133, 417\u2013446 (2017).","journal-title":"Int. Rev. Neurobiol."},{"key":"294_CR112","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.parkreldis.2013.06.009","volume":"19","author":"X Guo","year":"2013","unstructured":"Guo, X. et al. Gender and onset age-related features of non-motor symptoms of patients with Parkinson\u2019s disease \u2014 a study from Southwest China. Parkinsonism Relat. Disord. 19, 961\u2013965 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR113","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00415-011-6392-3","volume":"259","author":"P Martinez-Martin","year":"2012","unstructured":"Martinez-Martin, P. et al. Gender-related differences in\u00a0the burden of non-motor symptoms in Parkinson\u2019s disease. J. Neurol. 259, 1639\u20131647 (2012).","journal-title":"J. Neurol."},{"key":"294_CR114","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.parkreldis.2016.12.008","volume":"35","author":"A Nicoletti","year":"2017","unstructured":"Nicoletti, A. et al. Gender effect on non-motor symptoms in Parkinson\u2019s disease: are men more at risk? Parkinsonism Relat. Disord. 35, 69\u201374 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jns.2012.07.026","volume":"323","author":"P Solla","year":"2012","unstructured":"Solla, P. et al. Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson\u2019s disease. J. Neurol. Sci. 323, 33\u201339 (2012).","journal-title":"J. Neurol. Sci."},{"key":"294_CR116","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s10072-014-1879-1","volume":"35","author":"Y Song","year":"2014","unstructured":"Song, Y., Gu, Z., An, J. & Chan, P. Gender differences on motor and non-motor symptoms of de novo patients with early Parkinson\u2019s disease. Neurol. Sci. 35, 1991\u20131996 (2014).","journal-title":"Neurol. Sci."},{"key":"294_CR117","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mds.23528","volume":"26","author":"AFG Leentjens","year":"2011","unstructured":"Leentjens, A. F. G. et al. Symptomatology and markers of anxiety disorders in Parkinson\u2019s disease: a cross-sectional study. Mov. Disord. 26, 484\u2013492 (2011).","journal-title":"Mov. Disord."},{"key":"294_CR118","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1212\/WNL.0b013e3182a4a503","volume":"81","author":"AFG Leentjens","year":"2013","unstructured":"Leentjens, A. F. G. et al. Modeling depression in Parkinson disease: disease-specific and nonspecific risk factors. Neurology 81, 1036\u20131043 (2013).","journal-title":"Neurology"},{"key":"294_CR119","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.parkreldis.2013.09.025","volume":"20","author":"K Szewczyk-Krolikowski","year":"2014","unstructured":"Szewczyk-Krolikowski, K. et al. The influence of age and gender on motor and non-motor features of early Parkinson\u2019s disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsonism Relat. Disord. 20, 99\u2013105 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR120","first-page":"7951840","volume":"2016","author":"M Kovacs","year":"2016","unstructured":"Kovacs, M. et al. Impact of sex on the nonmotor symptoms and the health-related quality of life in Parkinson\u2019s disease. Parkinsons Dis. 2016, 7951840 (2016).","journal-title":"Parkinsons Dis."},{"key":"294_CR121","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s00415-013-7085-x","volume":"260","author":"M Picillo","year":"2013","unstructured":"Picillo, M. et al. Gender differences in non-motor symptoms in early, drug naive Parkinson\u2019s disease. J. Neurol. 260, 2849\u20132855 (2013).","journal-title":"J. Neurol."},{"key":"294_CR122","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/ene.13290","volume":"24","author":"M Picillo","year":"2017","unstructured":"Picillo, M. et al. The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson\u2019s disease. Eur. J. Neurol. 24, 788\u2013795 (2017).","journal-title":"Eur. J. Neurol."},{"key":"294_CR123","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/jnnp-2012-303419","volume":"84","author":"R Erro","year":"2013","unstructured":"Erro, R. et al. Non-motor symptoms in early Parkinson\u2019s disease: a 2-year follow-up study on previously untreated patients. J. Neurol. Neurosurg. Psychiatry 84, 14\u201317 (2013).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"294_CR124","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1212\/WNL.0000000000001609","volume":"84","author":"R Liu","year":"2015","unstructured":"Liu, R. et al. Potential sex differences in nonmotor symptoms in early drug-naive Parkinson disease. Neurology 84, 2107\u20132115 (2015).","journal-title":"Neurology"},{"key":"294_CR125","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.parkreldis.2014.04.023","volume":"20","author":"M Picillo","year":"2014","unstructured":"Picillo, M. et al. Gender differences in non-motor symptoms in early Parkinson\u2019s disease: a 2-years follow-up study on previously untreated patients. Parkinsonism Relat. Disord. 20, 850\u2013854 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR126","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/mds.25364","volume":"28","author":"C Warren Olanow","year":"2013","unstructured":"Warren Olanow, C. et al. Factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinson\u2019s disease. Mov. Disord. 28, 1064\u20131071 (2013).","journal-title":"Mov. Disord."},{"key":"294_CR127","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.parkreldis.2016.04.001","volume":"27","author":"M Picillo","year":"2016","unstructured":"Picillo, M. et al. Gender and non motor fluctuations in Parkinson\u2019s disease: a prospective study. Parkinsonism Relat. Disord. 27, 89\u201392 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR128","first-page":"63","volume":"5","author":"J Heller","year":"2014","unstructured":"Heller, J., Dogan, I., Schulz, J. B. & Reetz, K. Evidence for gender differences in cognition, emotion and quality of life in Parkinson\u2019s disease? Aging Dis. 5, 63\u201375 (2014).","journal-title":"Aging Dis."},{"key":"294_CR129","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000479111","volume":"17","author":"J-E Yoon","year":"2017","unstructured":"Yoon, J.-E. et al. Gender differences of nonmotor symptoms affecting quality of life in Parkinson disease. Neurodegener. Dis. 17, 276\u2013280 (2017).","journal-title":"Neurodegener. Dis."},{"key":"294_CR130","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(17)30122-9","volume":"16","author":"G Liu","year":"2017","unstructured":"Liu, G. et al. Prediction of cognition in Parkinson\u2019s disease with a clinical-genetic score: a longitudinal analysis of nine cohorts. Lancet Neurol. 16, 620\u2013629 (2017).","journal-title":"Lancet Neurol."},{"key":"294_CR131","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.parkreldis.2018.10.014","volume":"60","author":"AF Curtis","year":"2019","unstructured":"Curtis, A. F., Masellis, M., Camicioli, R., Davidson, H. & Tierney, M. C. Cognitive profile of non-demented Parkinson\u2019s disease: meta-analysis of domain and sex-specific deficits. Parkinsonism Relat. Disord. 60, 32\u201342 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR132","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1002\/mds.23388","volume":"25","author":"IN Miller","year":"2010","unstructured":"Miller, I. N. & Cronin-Golomb, A. Gender differences in Parkinson\u2019s disease: clinical characteristics and cognition. Mov. Disord. 25, 2695\u20132703 (2010).","journal-title":"Mov. Disord."},{"key":"294_CR133","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1212\/WNL.0b013e3181bf992f","volume":"73","author":"EY Uc","year":"2009","unstructured":"Uc, E. Y. et al. Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Neurology 73, 1469\u20131477 (2009).","journal-title":"Neurology"},{"key":"294_CR134","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.0000000000000842","volume":"83","author":"JBM Anang","year":"2014","unstructured":"Anang, J. B. M. et al. Predictors of dementia in Parkinson disease: a prospective cohort study. Neurology 83, 1253\u20131260 (2014).","journal-title":"Neurology"},{"key":"294_CR135","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1212\/WNL.0000000000002001","volume":"85","author":"K Pigott","year":"2015","unstructured":"Pigott, K. et al. Longitudinal study of normal cognition in Parkinson disease. Neurology 85, 1276\u20131282 (2015).","journal-title":"Neurology"},{"key":"294_CR136","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/JPD-160925","volume":"7","author":"JBM Anang","year":"2017","unstructured":"Anang, J. B. M. et al. Dementia predictors in Parkinson disease: a validation study. J. Parkinsons Dis. 7, 159\u2013162 (2017).","journal-title":"J. Parkinsons Dis."},{"key":"294_CR137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133002","volume":"10","author":"EF Augustine","year":"2015","unstructured":"Augustine, E. F. et al. Sex differences in clinical features of early, treated Parkinson\u2019s disease. PLOS ONE 10, e0133002 (2015).","journal-title":"PLOS ONE"},{"key":"294_CR138","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.parkreldis.2018.02.007","volume":"50","author":"B Cholerton","year":"2018","unstructured":"Cholerton, B. et al. Sex differences in progression to mild cognitive impairment and dementia in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 50, 29\u201336 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR139","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.parkreldis.2016.02.024","volume":"26","author":"E Cereda","year":"2016","unstructured":"Cereda, E. et al. Dementia in Parkinson\u2019s disease: is male gender a risk factor? Parkinsonism Relat. Disord. 26, 67\u201372 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR140","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00415-005-0835-7","volume":"252","author":"Y Baba","year":"2005","unstructured":"Baba, Y., Putzke, J. D., Whaley, N. R., Wszolek, Z. K. & Uitti, R. J. Gender and the Parkinson\u2019s disease phenotype. J. Neurol. 252, 1201\u20131205 (2005).","journal-title":"J. Neurol."},{"key":"294_CR141","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1468-1331.2009.02866.x","volume":"17","author":"D Nyholm","year":"2010","unstructured":"Nyholm, D., Karlsson, E., Lundberg, M. & Askmark, H. Large differences in levodopa dose requirement in Parkinson\u2019s disease: men use higher doses than women. Eur. J. Neurol. 17, 260\u2013266 (2010).","journal-title":"Eur. J. Neurol."},{"key":"294_CR142","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.parkreldis.2006.07.002","volume":"12","author":"JC Sharma","year":"2006","unstructured":"Sharma, J. C., Macnamara, L., Hasoon, M., Vassallo, M. & Ross, I. Cascade of levodopa dose and weight-related dyskinesia in Parkinson\u2019s disease (LD-WD-PD cascade). Parkinsonism Relat. Disord. 12, 499\u2013505 (2006).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR143","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1468-1331.2008.02106.x","volume":"15","author":"JC Sharma","year":"2008","unstructured":"Sharma, J. C., Ross, I. N., Rascol, O. & Brooks, D. Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight. Eur. J. Neurol. 15, 493\u2013496 (2008).","journal-title":"Eur. J. Neurol."},{"key":"294_CR144","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1212\/WNL.58.9.1418","volume":"58","author":"K Kompoliti","year":"2002","unstructured":"Kompoliti, K. et al. Gender and pramipexole effects on\u00a0levodopa pharmacokinetics and pharmacodynamics. Neurology 58, 1418\u20131422 (2002).","journal-title":"Neurology"},{"issue":"Suppl. 2","key":"294_CR145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s100720200066","volume":"23","author":"G Arabia","year":"2002","unstructured":"Arabia, G. et al. Body weight, levodopa pharmacokinetics and dyskinesia in Parkinson\u2019s disease. Neurol. Sci. 23 (Suppl. 2), 53\u201354 (2002).","journal-title":"Neurol. Sci."},{"key":"294_CR146","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/WNF.0000000000000051","volume":"37","author":"T Kumagai","year":"2014","unstructured":"Kumagai, T. et al. Sex differences in the pharmacokinetics of levodopa in elderly patients with Parkinson disease. Clin. Neuropharmacol. 37, 173\u2013176 (2014).","journal-title":"Clin. Neuropharmacol."},{"key":"294_CR147","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s10072-003-0125-z","volume":"24","author":"P Martinelli","year":"2003","unstructured":"Martinelli, P. et al. Levodopa pharmacokinetics and dyskinesias: are there sex-related differences? Neurol. Sci. 24, 192\u2013193 (2003).","journal-title":"Neurol. Sci."},{"key":"294_CR148","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/brain\/awm113","volume":"130","author":"C Montaurier","year":"2007","unstructured":"Montaurier, C. et al. Mechanisms of body weight gain in patients with Parkinson\u2019s disease after subthalamic stimulation. Brain J. Neurol. 130, 1808\u20131818 (2007).","journal-title":"Brain J. Neurol."},{"key":"294_CR149","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/jcph.1096","volume":"58","author":"TF Sampaio","year":"2018","unstructured":"Sampaio, T. F. et al. MAO-B and COMT genetic variations associated with levodopa treatment response in patients with Parkinson\u2019s disease. J. Clin. Pharmacol. 58, 920\u2013926 (2018).","journal-title":"J. Clin. Pharmacol."},{"key":"294_CR150","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/mds.27372","volume":"33","author":"SH Fox","year":"2018","unstructured":"Fox, S. H. et al. International Parkinson and Movement Disorder Society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson\u2019s disease. Mov. Disord. 33, 1248\u20131266 (2018).","journal-title":"Mov. Disord."},{"key":"294_CR151","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","volume":"34","author":"K Seppi","year":"2019","unstructured":"Seppi, K. et al. Update on treatments for nonmotor symptoms of Parkinson\u2019s disease-an evidence-based medicine review. Mov. Disord. 34, 180\u2013198 (2019).","journal-title":"Mov. Disord."},{"key":"294_CR152","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/jamaneurol.2013.5798","volume":"71","author":"AK Chan","year":"2014","unstructured":"Chan, A. K. et al. Disparities in access to deep brain stimulation surgery for Parkinson disease: interaction between African American race and Medicaid use. JAMA Neurol. 71, 291\u2013299 (2014).","journal-title":"JAMA Neurol."},{"key":"294_CR153","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1212\/WNL.0000000000000017","volume":"82","author":"AW Willis","year":"2014","unstructured":"Willis, A. W. et al. Disparities in deep brain stimulation surgery among insured elders with Parkinson disease. Neurology 82, 163\u2013171 (2014).","journal-title":"Neurology"},{"key":"294_CR154","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.parkreldis.2010.12.002","volume":"17","author":"G-M Hariz","year":"2011","unstructured":"Hariz, G.-M. et al. Gender distribution of patients with Parkinson\u2019s disease treated with subthalamic deep brain stimulation; a review of the 2000-2009 literature. Parkinsonism Relat. Disord. 17, 146\u2013149 (2011).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/ane.12127","volume":"128","author":"G-M Hariz","year":"2013","unstructured":"Hariz, G.-M. et al. Gender differences in quality of life following subthalamic stimulation for Parkinson\u2019s disease. Acta Neurol. Scand. 128, 281\u2013285 (2013).","journal-title":"Acta Neurol. Scand."},{"key":"294_CR156","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00415-009-5381-2","volume":"257","author":"LM Romito","year":"2010","unstructured":"Romito, L. M., Contarino, F. M. & Albanese, A. Transient gender-related effects in Parkinson\u2019s disease patients with subthalamic stimulation. J. Neurol. 257, 603\u2013608 (2010).","journal-title":"J. Neurol."},{"key":"294_CR157","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/mds.21520","volume":"22","author":"E Accolla","year":"2007","unstructured":"Accolla, E. et al. Gender differences in patients with Parkinson\u2019s disease treated with subthalamic deep brain stimulation. Mov. Disord. 22, 1150\u20131156 (2007).","journal-title":"Mov. Disord."},{"key":"294_CR158","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fneur.2015.00191","volume":"6","author":"E Scelzo","year":"2015","unstructured":"Scelzo, E. et al. Deep brain stimulation during pregnancy and delivery: experience from a series of \u2018DBS babies\u2019. Front. Neurol. 6, 191 (2015).","journal-title":"Front. Neurol."},{"key":"294_CR159","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.27121","volume":"33","author":"KP Bhatia","year":"2018","unstructured":"Bhatia, K. P. et al. Consensus statement on the classification of tremors, from the Task Force on Tremor of the International Parkinson and Movement Disorder Society. Mov. Disord. 33, 75\u201387 (2018).","journal-title":"Mov. Disord."},{"key":"294_CR160","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/mds.22838","volume":"25","author":"ED Louis","year":"2010","unstructured":"Louis, E. D. & Ferreira, J. J. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov. Disord. 25, 534\u2013541 (2010).","journal-title":"Mov. Disord."},{"key":"294_CR161","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000195691","volume":"32","author":"ED Louis","year":"2009","unstructured":"Louis, E. D., Thawani, S. P. & Andrews, H. F. Prevalence of essential tremor in a multiethnic, community-based study in northern Manhattan, New York, NY. Neuroepidemiology 32, 208\u2013214 (2009).","journal-title":"Neuroepidemiology"},{"key":"294_CR162","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/mds.22324","volume":"24","author":"A Glik","year":"2009","unstructured":"Glik, A. et al. Essential tremor might be less frequent than Parkinson\u2019s disease in North Israel Arab villages. Mov. Disord. 24, 119\u2013122 (2009).","journal-title":"Mov. Disord."},{"key":"294_CR163","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/mds.21349","volume":"22","author":"ML Mancini","year":"2007","unstructured":"Mancini, M. L. et al. Prevalence of essential tremor in the territory of lake Trasimeno, Italy: results of a population-based study. Mov. Disord. 22, 540\u2013545 (2007).","journal-title":"Mov. Disord."},{"key":"294_CR164","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/jnnp.2007.134304","volume":"79","author":"CL Dotchin","year":"2008","unstructured":"Dotchin, C. L. & Walker, R. W. The prevalence of essential tremor in rural northern Tanzania. J. Neurol. Neurosurg. Psychiatry 79, 1107\u20131109 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"294_CR165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.parkreldis.2005.01.002","volume":"11","author":"LCS Tan","year":"2005","unstructured":"Tan, L. C. S., Venketasubramanian, N., Ramasamy, V., Gao, W. & Saw, S.-M. Prevalence of essential tremor in Singapore: a study on three races in an Asian country. Parkinsonism Relat. Disord. 11, 233\u2013239 (2005).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR166","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/mds.21731","volume":"23","author":"ED Louis","year":"2008","unstructured":"Louis, E. D. & Vonsattel, J. P. G. The emerging neuropathology of essential tremor. Mov. Disord. 23, 174\u2013182 (2008).","journal-title":"Mov. Disord."},{"key":"294_CR167","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mds.20483","volume":"20","author":"ED Louis","year":"2005","unstructured":"Louis, E. D., Fernandez-Alvarez, E., Dure, L. S. 4th, Frucht, S. & Ford, B. Association between male gender and pediatric essential tremor. Mov. Disord. 20, 904\u2013906 (2005).","journal-title":"Mov. Disord."},{"key":"294_CR168","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/jnnp.47.5.466","volume":"47","author":"AH Rajput","year":"1984","unstructured":"Rajput, A. H., Offord, K. P., Beard, C. M. & Kurland, L. T. Essential tremor in Rochester, Minnesota: a 45-year study. J. Neurol. Neurosurg. Psychiatry 47, 466\u2013470 (1984).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"294_CR169","first-page":"1","volume":"36","author":"T Larsson","year":"1960","unstructured":"Larsson, T. & Sjogren, T. Essential tremor: a clinical and genetic population study. Acta Psychiatr. Scand. Suppl. 36, 1\u2013176 (1960).","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"294_CR170","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/mds.870120620","volume":"12","author":"JP Hubble","year":"1997","unstructured":"Hubble, J. P., Busenbark, K. L., Pahwa, R., Lyons, K. & Koller, W. C. Clinical expression of essential tremor: effects of gender and age. Mov. Disord. 12, 969\u2013972 (1997).","journal-title":"Mov. Disord."},{"key":"294_CR171","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/mds.20096","volume":"19","author":"DE Hardesty","year":"2004","unstructured":"Hardesty, D. E., Maraganore, D. M., Matsumoto, J. Y. & Louis, E. D. Increased risk of head tremor in women with essential tremor: longitudinal data from the Rochester Epidemiology Project. Mov. Disord. 19, 529\u2013533 (2004).","journal-title":"Mov. Disord."},{"key":"294_CR172","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.parkreldis.2017.04.012","volume":"40","author":"W Chen","year":"2017","unstructured":"Chen, W. et al. Topography of essential tremor. Parkinsonism Relat. Disord. 40, 58\u201363 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR173","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017248","volume":"7","author":"AA Veroniki","year":"2017","unstructured":"Veroniki, A. A. et al. Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis. BMJ Open. 7, e017248 (2017).","journal-title":"BMJ Open."},{"key":"294_CR174","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1055\/s-2007-991128","volume":"27","author":"YM Bordelon","year":"2007","unstructured":"Bordelon, Y. M. & Smith, M. Movement disorders in\u00a0pregnancy. Semin. Neurol. 27, 467\u2013475 (2007).","journal-title":"Semin. Neurol."},{"key":"294_CR175","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/mds.23071","volume":"25","author":"SM Kranick","year":"2010","unstructured":"Kranick, S. M., Mowry, E. M., Colcher, A., Horn, S. & Golbe, L. I. Movement disorders and pregnancy: a review of the literature. Mov. Disord. 25, 665\u2013671 (2010).","journal-title":"Mov. Disord."},{"key":"294_CR176","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.parkreldis.2011.05.014","volume":"17","author":"P Blomstedt","year":"2011","unstructured":"Blomstedt, P. et al. Influence of age, gender and severity of tremor on outcome after thalamic and\u00a0subthalamic DBS for essential tremor. Parkinsonism Relat. Disord. 17, 617\u2013620 (2011).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR177","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","volume":"28","author":"A Albanese","year":"2013","unstructured":"Albanese, A. et al. Phenomenology and classification of dystonia: a consensus update. Mov. Disord. 28, 863\u2013873 (2013).","journal-title":"Mov. Disord."},{"key":"294_CR178","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/mds.25567","volume":"28","author":"HA Jinnah","year":"2013","unstructured":"Jinnah, H. A. et al. The focal dystonias: current views and challenges for future research. Mov. Disord. 28, 926\u2013943 (2013).","journal-title":"Mov. Disord."},{"key":"294_CR179","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/mds.25244","volume":"27","author":"TD Steeves","year":"2012","unstructured":"Steeves, T. D., Day, L., Dykeman, J., Jette, N. & Pringsheim, T. The prevalence of primary dystonia: a systematic review and meta-analysis. Mov. Disord. 27, 1789\u20131796 (2012).","journal-title":"Mov. Disord."},{"issue":"Suppl. 1","key":"294_CR180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-1331.2010.03053.x","volume":"17","author":"G Defazio","year":"2010","unstructured":"Defazio, G. The epidemiology of primary dystonia: current evidence and perspectives. Eur. J. Neurol. 17 (Suppl. 1), 9\u201314 (2010).","journal-title":"Eur. J. Neurol."},{"key":"294_CR181","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(04)00907-X","volume":"3","author":"G Defazio","year":"2004","unstructured":"Defazio, G., Abbruzzese, G., Livrea, P. & Berardelli, A. Epidemiology of primary dystonia. Lancet Neurol. 3, 673\u2013678 (2004).","journal-title":"Lancet Neurol."},{"key":"294_CR182","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/ene.13133","volume":"24","author":"L Williams","year":"2017","unstructured":"Williams, L. et al. Epidemiological, clinical and genetic aspects of adult onset isolated focal dystonia in Ireland. Eur. J. Neurol. 24, 73\u201381 (2017).","journal-title":"Eur. J. Neurol."},{"key":"294_CR183","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/0194599817728521","volume":"157","author":"JM Hintze","year":"2017","unstructured":"Hintze, J. M., Ludlow, C. L., Bansberg, S. F., Adler, C. H. & Lott, D. G. Spasmodic dysphonia: a review. Part 1: pathogenic factors. Otolaryngol. Head. Neck Surg. 157, 551\u2013557 (2017).","journal-title":"Otolaryngol. Head. Neck Surg."},{"key":"294_CR184","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jns.2016.11.053","volume":"372","author":"S Pandey","year":"2017","unstructured":"Pandey, S. & Sharma, S. Meige\u2019s syndrome: history, epidemiology, clinical features, pathogenesis and treatment. J. Neurol. Sci. 372, 162\u2013170 (2017).","journal-title":"J. Neurol. Sci."},{"key":"294_CR185","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp.60.2.204","volume":"60","author":"VL Soland","year":"1996","unstructured":"Soland, V. L., Bhatia, K. P. & Marsden, C. D. Sex prevalence of focal dystonias. J. Neurol. Neurosurg. Psychiatry 60, 204\u2013205 (1996).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"294_CR186","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10072-017-2839-3","volume":"38","author":"G Defazio","year":"2017","unstructured":"Defazio, G. et al. The Italian Dystonia Registry: rationale, design and preliminary findings. Neurol. Sci. 38, 819\u2013825 (2017).","journal-title":"Neurol. Sci."},{"key":"294_CR187","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s004150070094","volume":"247","author":"Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group","year":"2000","unstructured":"The Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group. A prevalence study of primary dystonia in eight European countries. J. Neurol. 247, 787\u2013792 (2000).","journal-title":"J. Neurol."},{"key":"294_CR188","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1196\/annals.1444.012","volume":"1142","author":"D Torres-Russotto","year":"2008","unstructured":"Torres-Russotto, D. & Perlmutter, J. S. Task-specific dystonias: a review. Ann. N. Y. Acad. Sci. 1142, 179\u2013199 (2008).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"294_CR189","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/mds.25442","volume":"28","author":"S Dhungana","year":"2013","unstructured":"Dhungana, S. & Jankovic, J. Yips and other movement disorders in golfers. Mov. Disord. 28, 576\u2013581 (2013).","journal-title":"Mov. Disord."},{"key":"294_CR190","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/mds.23824","volume":"26","author":"CH Adler","year":"2011","unstructured":"Adler, C. H. et al. Are the yips a task-specific dystonia or \u2018golfer\u2019s cramp\u2019? Mov. Disord. 26, 1993\u20131996 (2011).","journal-title":"Mov. Disord."},{"key":"294_CR191","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/brain\/awl355","volume":"130","author":"G Defazio","year":"2007","unstructured":"Defazio, G., Berardelli, A. & Hallett, M. Do primary adult-onset focal dystonias share aetiological factors? Brain J. Neurol. 130, 1183\u20131193 (2007).","journal-title":"Brain J. Neurol."},{"key":"294_CR192","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jns.2016.10.028","volume":"371","author":"JH Ham","year":"2016","unstructured":"Ham, J. H. et al. A prognostic factor in focal hand dystonia: typist\u2019s cramp cases and literature review. J. Neurol. Sci. 371, 85\u201387 (2016).","journal-title":"J. Neurol. Sci."},{"key":"294_CR193","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrneurol.2015.86","volume":"11","author":"S Wijemanne","year":"2015","unstructured":"Wijemanne, S. & Jankovic, J. Dopa-responsive dystonia \u2014 clinical and genetic heterogeneity. Nat. Rev. Neurol. 11, 414\u2013424 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"294_CR194","volume":"17","author":"G Cossu","year":"2017","unstructured":"Cossu, G. & Colosimo, C. Hyperkinetic movement disorder emergencies. Curr. Neurol. Neurosci. Rep. 17, 6 (2017).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"294_CR195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jns.2018.02.005","volume":"389","author":"D Savitt","year":"2018","unstructured":"Savitt, D. & Jankovic, J. Tardive syndromes. J. Neurol. Sci. 389, 35\u201342 (2018).","journal-title":"J. Neurol. Sci."},{"key":"294_CR196","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/jnnp-2012-302729","volume":"83","author":"JL Groen","year":"2012","unstructured":"Groen, J. L. et al. Phenotypes and genetic architecture of focal primary torsion dystonia. J. Neurol. Neurosurg. Psychiatry 83, 1006\u20131011 (2012).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"294_CR197","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/jnnp.2007.131524","volume":"79","author":"M Fiorio","year":"2008","unstructured":"Fiorio, M. et al. Tactile temporal discrimination in patients with blepharospasm. J. Neurol. Neurosurg. Psychiatry 79, 796\u2013798 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"294_CR198","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/mds.25822","volume":"29","author":"O Kimmich","year":"2014","unstructured":"Kimmich, O. et al. Temporal discrimination, a cervical dystonia endophenotype: penetrance and functional correlates. Mov. Disord. 29, 804\u2013811 (2014).","journal-title":"Mov. Disord."},{"key":"294_CR199","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/brain\/awl283","volume":"130","author":"M Fiorio","year":"2007","unstructured":"Fiorio, M. et al. Defective temporal processing of sensory stimuli in DYT1 mutation carriers: a new endophenotype of dystonia? Brain J. Neurol. 130, 134\u2013142 (2007).","journal-title":"Brain J. Neurol."},{"key":"294_CR200","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/jnnp.2009.178236","volume":"80","author":"A Scontrini","year":"2009","unstructured":"Scontrini, A. et al. Somatosensory temporal discrimination in patients with primary focal dystonia. J. Neurol. Neurosurg. Psychiatry 80, 1315\u20131319 (2009).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"294_CR201","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1093\/brain\/awr194","volume":"134","author":"O Kimmich","year":"2011","unstructured":"Kimmich, O. et al. Sporadic adult onset primary torsion dystonia is a genetic disorder by the temporal discrimination test. Brain J. Neurol. 134, 2656\u20132663 (2011).","journal-title":"Brain J. Neurol."},{"key":"294_CR202","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fneur.2014.00054","volume":"5","author":"M Hutchinson","year":"2014","unstructured":"Hutchinson, M. et al. Cervical dystonia: a disorder of the midbrain network for covert attentional orienting. Front. Neurol. 5, 54 (2014).","journal-title":"Front. Neurol."},{"key":"294_CR203","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/epi.10.75","volume":"3","author":"CD Green","year":"2011","unstructured":"Green, C. D. & Han, J.-D. J. Epigenetic regulation by nuclear receptors. Epigenomics 3, 59\u201372 (2011).","journal-title":"Epigenomics"},{"key":"294_CR204","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0025-6196(11)65026-X","volume":"75","author":"KA Gwinn-Hardy","year":"2000","unstructured":"Gwinn-Hardy, K. A., Adler, C. H., Weaver, A. L., Fish, N. M. & Newman, S. J. Effect of hormone variations and other factors on symptom severity in women with dystonia. Mayo Clin. Proc. 75, 235\u2013240 (2000).","journal-title":"Mayo Clin. Proc."},{"key":"294_CR205","first-page":"163","volume":"64","author":"JD Rogers","year":"1994","unstructured":"Rogers, J. D. & Fahn, S. Movement disorders and pregnancy. Adv. Neurol. 64, 163\u2013178 (1994).","journal-title":"Adv. Neurol."},{"key":"294_CR206","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000047975","volume":"47","author":"D Martino","year":"2002","unstructured":"Martino, D. et al. Menopause and menarche in patients with primary blepharospasm: an exploratory case-control study. Eur. Neurol. 47, 161\u2013164 (2002).","journal-title":"Eur. Neurol."},{"key":"294_CR207","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng709","volume":"29","author":"A Zimprich","year":"2001","unstructured":"Zimprich, A. et al. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat. Genet. 29, 66\u201369 (2001).","journal-title":"Nat. Genet."},{"key":"294_CR208","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/mds.25536","volume":"28","author":"K Lohmann","year":"2013","unstructured":"Lohmann, K. & Klein, C. Genetics of dystonia: What\u2019s known? What\u2019s new? What\u2019s next? Mov. Disord. 28, 899\u2013905 (2013).","journal-title":"Mov. Disord."},{"issue":"Suppl. 1","key":"294_CR209","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/00207454.2010.526728","volume":"121","author":"LV Lee","year":"2011","unstructured":"Lee, L. V. et al. The unique phenomenology of sex-linked dystonia parkinsonism (XDP, DYT3, \u2018Lubag\u2019). Int. J. Neurosci. 121 (Suppl. 1), 3\u201311 (2011).","journal-title":"Int. J. Neurosci."},{"key":"294_CR210","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1212\/01.wnl.0000267425.51598.c9","volume":"69","author":"C Marras","year":"2007","unstructured":"Marras, C. et al. Minimum incidence of primary cervical dystonia in a multiethnic health care population. Neurology 69, 676\u2013680 (2007).","journal-title":"Neurology"},{"key":"294_CR211","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/mds.10480","volume":"18","author":"S Matsumoto","year":"2003","unstructured":"Matsumoto, S., Nishimura, M., Shibasaki, H. & Kaji, R. Epidemiology of primary dystonias in Japan: comparison with Western countries. Mov. Disord. 18, 1196\u20131198 (2003).","journal-title":"Mov. Disord."},{"key":"294_CR212","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.parkreldis.2015.07.003","volume":"21","author":"KJ Peall","year":"2015","unstructured":"Peall, K. J., Kuiper, A., de Koning, T. J. & Tijssen, M. A. J. Non-motor symptoms in genetically defined dystonia: homogenous groups require systematic assessment. Parkinsonism Relat. Disord. 21, 1031\u20131040 (2015).","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Suppl. 1","key":"294_CR213","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.parkreldis.2015.09.001","volume":"22","author":"A Conte","year":"2016","unstructured":"Conte, A. et al. Non-motor symptoms in patients with adult-onset focal dystonia: sensory and psychiatric disturbances. Parkinsonism Relat. Disord. 22 (Suppl. 1), 111\u2013114 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR214","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.parkreldis.2018.08.008","volume":"58","author":"H Eggink","year":"2019","unstructured":"Eggink, H. et al. Motor and non-motor determinants of health-related quality of life in young dystonia patients. Parkinsonism Relat. Disord. 58, 50\u201355 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR215","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5334\/tohm.466","volume":"9","author":"N Novaretti","year":"2019","unstructured":"Novaretti, N. et al. The prevalence and correlation of non-motor symptoms in adult patients with idiopathic focal or segmental dystonia. Tremor Other Hyperkinetic Mov. 9, 596 (2019).","journal-title":"Tremor Other Hyperkinetic Mov."},{"key":"294_CR216","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1212\/WNL.0000000000003596","volume":"88","author":"S Pirio Richardson","year":"2017","unstructured":"Pirio Richardson, S., Wegele, A. R., Skipper, B., Deligtisch, A. & Jinnah, H. A. Dystonia treatment: patterns of medication use in an international cohort. Neurology 88, 543\u2013550 (2017).","journal-title":"Neurology"},{"key":"294_CR217","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fneur.2017.00035","volume":"8","author":"MF Contarino","year":"2017","unstructured":"Contarino, M. F. et al. Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin. Front. Neurol. 8, 35 (2017).","journal-title":"Front. Neurol."},{"key":"294_CR218","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000444266","volume":"94","author":"N Ziman","year":"2016","unstructured":"Ziman, N. et al. Pregnancy in a series of dystonia patients treated with deep brain stimulation: outcomes and management recommendations. Stereotact. Funct. Neurosurg. 94, 60\u201365 (2016).","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"294_CR219","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/mds.20777","volume":"21","author":"A Paluzzi","year":"2006","unstructured":"Paluzzi, A. et al. Pregnancy in dystonic women with in situ deep brain stimulators. Mov. Disord. 21, 695\u2013698 (2006).","journal-title":"Mov. Disord."},{"key":"294_CR220","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Prim. 1, 15005 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"294_CR221","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald, M. E. et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72, 971\u2013983 (1993).","journal-title":"Cell"},{"key":"294_CR222","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.niox.2018.12.002","volume":"83","author":"FE Padovan-Neto","year":"2019","unstructured":"Padovan-Neto, F. E. et al. Age- and sex-related changes in cortical and striatal nitric oxide synthase in the Q175 mouse model of Huntington\u2019s disease. Nitric Oxide 83, 40\u201350 (2019).","journal-title":"Nitric Oxide"},{"key":"294_CR223","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbr.2006.12.004","volume":"178","author":"JL Dorner","year":"2007","unstructured":"Dorner, J. L., Miller, B. R., Barton, S. J., Brock, T. J. & Rebec, G. V. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington\u2019s disease. Behav. Brain Res. 178, 90\u201397 (2007).","journal-title":"Behav. Brain Res."},{"key":"294_CR224","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/hmg\/ddn159","volume":"17","author":"FJ Bode","year":"2008","unstructured":"Bode, F. J. et al. Sex differences in a transgenic rat model of Huntington\u2019s disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males. Hum. Mol. Genet. 17, 2595\u20132609 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"294_CR225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/mds.25717","volume":"29","author":"ER Fisher","year":"2014","unstructured":"Fisher, E. R. & Hayden, M. R. Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk. Mov. Disord. 29, 105\u2013114 (2014).","journal-title":"Mov. Disord."},{"key":"294_CR226","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","volume":"27","author":"T Pringsheim","year":"2012","unstructured":"Pringsheim, T. et al. The incidence and prevalence of Huntington\u2019s disease: a systematic review and meta-analysis. Mov. Disord. 27, 1083\u20131091 (2012).","journal-title":"Mov. Disord."},{"key":"294_CR227","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/mds.27653","volume":"34","author":"E Bruzelius","year":"2019","unstructured":"Bruzelius, E. et al. Huntington\u2019s disease in the United States: variation by demographic and socioeconomic factors. Mov. Disord. 34, 858\u2013865 (2019).","journal-title":"Mov. Disord."},{"key":"294_CR228","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng0893-387","volume":"4","author":"M Duyao","year":"1993","unstructured":"Duyao, M. et al. Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease. Nat. Genet. 4, 387\u2013392 (1993).","journal-title":"Nat. Genet."},{"key":"294_CR229","first-page":"108","volume":"36","author":"P Kehoe","year":"1999","unstructured":"Kehoe, P., Krawczak, M., Harper, P. S., Owen, M. J. & Jones, A. L. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. J. Med. Genet. 36, 108\u2013111 (1999).","journal-title":"J. Med. Genet."},{"key":"294_CR230","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jnr.23980","volume":"95","author":"JK Lee","year":"2017","unstructured":"Lee, J. K. et al. Sex-specific effects of the Huntington gene on normal neurodevelopment. J. Neurosci. Res. 95, 398\u2013408 (2017).","journal-title":"J. Neurosci. Res."},{"key":"294_CR231","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1016\/j.ejmg.2011.04.002","volume":"54","author":"NA Aziz","year":"2011","unstructured":"Aziz, N. A., van Belzen, M. J., Coops, I. D., Belfroid, R. D. M. & Roos, R. A. C. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington\u2019s disease. Eur. J. Med. Genet. 54, e413\u2013e418 (2011).","journal-title":"Eur. J. Med. Genet."},{"key":"294_CR232","first-page":"593","volume":"57","author":"NG Ranen","year":"1995","unstructured":"Ranen, N. G. et al. Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease. Am. J. Hum. Genet. 57, 593\u2013602 (1995).","journal-title":"Am. J. Hum. Genet."},{"key":"294_CR233","first-page":"343","volume":"57","author":"B Kremer","year":"1995","unstructured":"Kremer, B. et al. Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes. Am. J. Hum. Genet. 57, 343\u2013350 (1995).","journal-title":"Am. J. Hum. Genet."},{"key":"294_CR234","first-page":"528","volume":"50","author":"LA Farrer","year":"1992","unstructured":"Farrer, L. A., Cupples, L. A., Kiely, D. K., Conneally, P. M. & Myers, R. H. Inverse relationship between age at onset of Huntington disease and paternal age suggests involvement of genetic imprinting. Am. J. Hum. Genet. 50, 528\u2013535 (1992).","journal-title":"Am. J. Hum. Genet."},{"key":"294_CR235","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.parkreldis.2012.09.012","volume":"19","author":"D Zielonka","year":"2013","unstructured":"Zielonka, D. et al. The influence of gender on phenotype and disease progression in patients with Huntington\u2019s disease. Parkinsonism Relat. Disord. 19, 192\u2013197 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR236","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/jnnp.66.1.52","volume":"66","author":"T Foroud","year":"1999","unstructured":"Foroud, T., Gray, J., Ivashina, J. & Conneally, P. M. Differences in duration of Huntington\u2019s disease based on age at onset. J. Neurol. Neurosurg. Psychiatry 66, 52\u201356 (1999).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"294_CR237","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/archneur.1991.00530200036015","volume":"48","author":"RH Myers","year":"1991","unstructured":"Myers, R. H. et al. Factors associated with slow progression in Huntington\u2019s disease. Arch. Neurol. 48, 800\u2013804 (1991).","journal-title":"Arch. Neurol."},{"key":"294_CR238","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.parkreldis.2018.01.006","volume":"49","author":"D Zielonka","year":"2018","unstructured":"Zielonka, D. et al. The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington\u2019s disease. Parkinsonism Relat. Disord. 49, 42\u201347 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR239","first-page":"199","volume":"28","author":"M Markianos","year":"2007","unstructured":"Markianos, M., Panas, M., Kalfakis, N. & Vassilopoulos, D. Plasma testosterone, dehydroepiandrosterone sulfate, and cortisol in female patients with Huntington\u2019s disease. Neuro Endocrinol. Lett. 28, 199\u2013203 (2007).","journal-title":"Neuro Endocrinol. Lett."},{"key":"294_CR240","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.20428","volume":"57","author":"M Markianos","year":"2005","unstructured":"Markianos, M., Panas, M., Kalfakis, N. & Vassilopoulos, D. Plasma testosterone in male patients with Huntington\u2019s disease: relations to severity of illness and dementia. Ann. Neurol. 57, 520\u2013525 (2005).","journal-title":"Ann. Neurol."},{"key":"294_CR241","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","volume":"85","author":"E van Duijn","year":"2014","unstructured":"van Duijn, E. et al. Neuropsychiatric symptoms in a European Huntington\u2019s disease cohort (REGISTRY). J. Neurol. Neurosurg. Psychiatry 85, 1411\u20131418 (2014).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"294_CR242","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpsychores.2015.11.003","volume":"80","author":"M Dale","year":"2016","unstructured":"Dale, M., Maltby, J., Shimozaki, S., Cramp, R. & Rickards, H. Disease stage, but not sex, predicts depression and psychological distress in Huntington\u2019s disease: a European population study. J. Psychosom. Res. 80, 17\u201322 (2016).","journal-title":"J. Psychosom. Res."},{"key":"294_CR243","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.nut.2018.08.005","volume":"59","author":"R Costa de Miranda","year":"2019","unstructured":"Costa de Miranda, R. et al. Body composition and bone mineral density in Huntington\u2019s disease. Nutrition 59, 145\u2013149 (2019).","journal-title":"Nutrition"},{"key":"294_CR244","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","volume":"66","author":"Huntington Study Group","year":"2006","unstructured":"Huntington Study Group. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology 66, 366\u2013372 (2006).","journal-title":"Neurology"},{"key":"294_CR245","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/WNF.0b013e3180ca77ea","volume":"31","author":"S Frank","year":"2008","unstructured":"Frank, S. et al. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease. Clin. Neuropharmacol. 31, 127\u2013133 (2008).","journal-title":"Clin. Neuropharmacol."},{"key":"294_CR246","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-9-62","volume":"9","author":"S Frank","year":"2009","unstructured":"Frank, S. Huntington Study Group\/TETRA-HD Investigators. Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. BMC Neurol. 9, 62 (2009).","journal-title":"BMC Neurol."},{"key":"294_CR247","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/mdc3.12706","volume":"6","author":"JL Schultz","year":"2019","unstructured":"Schultz, J. L., Kamholz, J. A., Nopoulos, P. C. & Killoran, A. Comparing risperidone and olanzapine to tetrabenazine for the management of chorea in Huntington disease: an analysis from the Enroll-HD database. Mov. Disord. Clin. Pract. 6, 132\u2013138 (2019).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"294_CR248","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.psychres.2011.09.005","volume":"196","author":"KC Rowe","year":"2012","unstructured":"Rowe, K. C. et al. Patterns of serotonergic antidepressant usage in prodromal Huntington disease. Psychiatry Res. 196, 309\u2013314 (2012).","journal-title":"Psychiatry Res."},{"key":"294_CR249","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s40263-018-0517-5","volume":"32","author":"P Damkier","year":"2018","unstructured":"Damkier, P. & Videbech, P. The safety of second-generation antipsychotics during pregnancy: a clinically focused review. CNS Drugs 32, 351\u2013366 (2018).","journal-title":"CNS Drugs"},{"key":"294_CR250","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1542\/peds.105.4.880","volume":"105","author":"Committee on Drugs","year":"2000","unstructured":"Committee on Drugs. Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Pediatrics 105, 880\u2013887 (2000).","journal-title":"Pediatrics"},{"key":"294_CR251","unstructured":"Beier, K. & Pratt, D. P. Sydenham chorea. StatPearls https:\/\/www.statpearls.com\/as\/genetics\/29792\/ (2019)."},{"key":"294_CR252","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/archneur.59.5.868","volume":"59","author":"F Cardoso","year":"2002","unstructured":"Cardoso, F. Chorea gravidarum. Arch. Neurol. 59, 868\u2013870 (2002).","journal-title":"Arch. Neurol."},{"key":"294_CR253","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.parkreldis.2011.12.013","volume":"18","author":"DP Maia","year":"2012","unstructured":"Maia, D. P. et al. Pregnancy in patients with Sydenham\u2019s chorea. Parkinsonism Relat. Disord. 18, 458\u2013461 (2012).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR254","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/bs.irn.2017.05.006","volume":"134","author":"D Martino","year":"2017","unstructured":"Martino, D., Ganos, C. & Pringsheim, T. M. Tourette syndrome and chronic tic disorders: the clinical spectrum beyond tics. Int. Rev. Neurobiol. 134, 1461\u20131490 (2017).","journal-title":"Int. Rev. Neurobiol."},{"key":"294_CR255","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ana.410220317","volume":"22","author":"G Erenberg","year":"1987","unstructured":"Erenberg, G., Cruse, R. P. & Rothner, A. D. The natural history of Tourette syndrome: a follow-up study. Ann. Neurol. 22, 383\u2013385 (1987).","journal-title":"Ann. Neurol."},{"key":"294_CR256","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1017\/S0317167100038087","volume":"14","author":"J Jankovic","year":"1987","unstructured":"Jankovic, J. & Rohaidy, H. Motor, behavioral and pharmacologic findings in Tourette\u2019s syndrome. Can. J. Neurol. Sci. 14, 541\u2013546 (1987).","journal-title":"Can. J. Neurol. Sci."},{"key":"294_CR257","first-page":"435","volume":"37","author":"DE Comings","year":"1985","unstructured":"Comings, D. E. & Comings, B. G. Tourette syndrome: clinical and psychological aspects of 250 cases. Am. J. Hum. Genet. 37, 435\u2013450 (1985).","journal-title":"Am. J. Hum. Genet."},{"key":"294_CR258","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1600-0404.2003.00228.x","volume":"109","author":"V Eapen","year":"2004","unstructured":"Eapen, V., Fox-Hiley, P., Banerjee, S. & Robertson, M. Clinical features and associated psychopathology in a Tourette syndrome cohort. Acta Neurol. Scand. 109, 255\u2013260 (2004).","journal-title":"Acta Neurol. Scand."},{"key":"294_CR259","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1017\/S0012162200000839","volume":"42","author":"RD Freeman","year":"2000","unstructured":"Freeman, R. D. et al. An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev. Med. Child. Neurol. 42, 436\u2013447 (2000).","journal-title":"Dev. Med. Child. Neurol."},{"key":"294_CR260","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1939-0025.1964.tb02212.x","volume":"34","author":"R Lapouse","year":"1964","unstructured":"Lapouse, R. & Monk, M. A. Behavior deviations in a representative sample of children: variation by sex, age, race, social class and family size. Am. J. Orthopsychiatry 34, 436\u2013446 (1964).","journal-title":"Am. J. Orthopsychiatry"},{"key":"294_CR261","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-3999(02)00580-9","volume":"55","author":"MM Robertson","year":"2003","unstructured":"Robertson, M. M. Diagnosing Tourette syndrome: is it a common disorder? J. Psychosom. Res. 55, 3\u20136 (2003).","journal-title":"J. Psychosom. Res."},{"key":"294_CR262","first-page":"240","volume":"96","author":"L Scahill","year":"2005","unstructured":"Scahill, L., Sukhodolsky, D. G., Williams, S. K. & Leckman, J. F. Public health significance of tic disorders in children and adolescents. Adv. Neurol. 96, 240\u2013248 (2005).","journal-title":"Adv. Neurol."},{"key":"294_CR263","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jpsychores.2008.03.006","volume":"65","author":"MM Robertson","year":"2008","unstructured":"Robertson, M. M. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J. Psychosom. Res. 65, 461\u2013472 (2008).","journal-title":"J. Psychosom. Res."},{"key":"294_CR264","first-page":"67","volume":"58","author":"J Kerbeshian","year":"1992","unstructured":"Kerbeshian, J. & Burd, L. Epidemiology and comorbidity. The North Dakota prevalence studies of Tourette syndrome and other developmental disorders. Adv. Neurol. 58, 67\u201374 (1992).","journal-title":"Adv. Neurol."},{"key":"294_CR265","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.eurpsy.2009.10.003","volume":"26","author":"M Schlander","year":"2011","unstructured":"Schlander, M., Schwarz, O., Rothenberger, A. & Roessner, V. Tic disorders: administrative prevalence and co-occurrence with attention-deficit\/hyperactivity disorder in a German community sample. Eur.\u00a0Psychiatry 26, 370\u2013374 (2011).","journal-title":"Eur. Psychiatry"},{"key":"294_CR266","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/B978-0-12-411546-0.00009-3","volume":"112","author":"D Martino","year":"2013","unstructured":"Martino, D., Macerollo, A. & Leckman, J. F. Neuroendocrine aspects of Tourette syndrome. Int. Rev. Neurobiol. 112, 239\u2013279 (2013).","journal-title":"Int. Rev. Neurobiol."},{"key":"294_CR267","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/archdischild-2011-300585","volume":"97","author":"MM Robertson","year":"2012","unstructured":"Robertson, M. M. The Gilles de la Tourette syndrome: the current status. Arch. Dis. Child. Educ. Pract. Ed. 97, 166\u2013175 (2012).","journal-title":"Arch. Dis. Child. Educ. Pract. Ed."},{"key":"294_CR268","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00787-010-0115-7","volume":"19","author":"MG Motlagh","year":"2010","unstructured":"Motlagh, M. G. et al. Severe psychosocial stress and heavy cigarette smoking during pregnancy: an examination of the pre- and perinatal risk factors associated with ADHD and Tourette syndrome. Eur. Child. Adolesc. Psychiatry 19, 755\u2013764 (2010).","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"key":"294_CR269","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jaac.2015.03.008","volume":"54","author":"S Dalsgaard","year":"2015","unstructured":"Dalsgaard, S., Waltoft, B. L., Leckman, J. F. & Mortensen, P. B. Maternal history of autoimmune disease and later development of Tourette syndrome in offspring. J. Am. Acad. Child. Adolesc. Psychiatry 54, 495\u2013501.e1 (2015).","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"294_CR270","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cortex.2009.06.008","volume":"46","author":"C Fahim","year":"2010","unstructured":"Fahim, C. et al. Somatosensory-motor bodily representation cortical thinning in Tourette: effects of tic severity, age and gender. Cortex 46, 750\u2013760 (2010).","journal-title":"Cortex"},{"key":"294_CR271","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/WNL.45.5.924","volume":"45","author":"DG Lichter","year":"1995","unstructured":"Lichter, D. G., Jackson, L. A. & Schachter, M. Clinical evidence of genomic imprinting in Tourette\u2019s syndrome. Neurology 45, 924\u2013928 (1995).","journal-title":"Neurology"},{"key":"294_CR272","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamapsychiatry.2015.0627","volume":"72","author":"D Mataix-Cols","year":"2015","unstructured":"Mataix-Cols, D. et al. Familial risks of Tourette syndrome and chronic tic disorders. A population-based cohort study. JAMA Psychiatry 72, 787\u2013793 (2015).","journal-title":"JAMA Psychiatry"},{"key":"294_CR273","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1017\/S0033291716002981","volume":"47","author":"NR Zilhao","year":"2017","unstructured":"Zilhao, N. R. et al. Heritability of tic disorders: a twin-family study. Psychol. Med. 47, 1085\u20131096 (2017).","journal-title":"Psychol. Med."},{"key":"294_CR274","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.2018.18070857","volume":"176","author":"D Yu","year":"2019","unstructured":"Yu, D. et al. Interrogating the genetic determinants of Tourette\u2019s syndrome and other tic disorders through genome-wide association studies. Am. J. Psychiatry 176, 217\u2013227 (2019).","journal-title":"Am. J. Psychiatry"},{"key":"294_CR275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0887-8994(92)90051-Y","volume":"8","author":"MJ Schwabe","year":"1992","unstructured":"Schwabe, M. J. & Konkol, R. J. Menstrual cycle-related fluctuations of tics in Tourette syndrome. Pediatr. Neurol. 8, 43\u201346 (1992).","journal-title":"Pediatr. Neurol."},{"key":"294_CR276","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.parkreldis.2019.02.005","volume":"59","author":"D Martino","year":"2019","unstructured":"Martino, D. & Hedderly, T. Tics and stereotypies: a comparative clinical review. Parkinsonism Relat. Disord. 59, 117\u2013124 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"294_CR277","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00004583-199407000-00004","volume":"33","author":"SL Santangelo","year":"1994","unstructured":"Santangelo, S. L. et al. Tourette\u2019s syndrome: what are the influences of gender and comorbid obsessive\u2013compulsive disorder? J. Am. Acad. Child. Adolesc. Psychiatry 33, 795\u2013804 (1994).","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"294_CR278","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/ene.12274","volume":"21","author":"S Rodgers","year":"2014","unstructured":"Rodgers, S. et al. Sex-related and non-sex-related comorbidity subtypes of tic disorders: a latent class approach. Eur. J. Neurol. 21, 700\u2013707 (2014).","journal-title":"Eur. J. Neurol."},{"key":"294_CR279","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.comppsych.2011.07.004","volume":"53","author":"AB Lewin","year":"2012","unstructured":"Lewin, A. B. et al. A phenomenological investigation of women with Tourette or other chronic tic disorders. Compr. Psychiatry 53, 525\u2013534 (2012).","journal-title":"Compr. Psychiatry"},{"key":"294_CR280","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/088307389701200705","volume":"12","author":"LJ Schuerholz","year":"1997","unstructured":"Schuerholz, L. J., Cutting, L., Mazzocco, M. M., Singer, H. S. & Denckla, M. B. Neuromotor functioning in children with Tourette syndrome with and without attention deficit hyperactivity disorder. J. Child. Neurol. 12, 438\u2013442 (1997).","journal-title":"J. Child. Neurol."},{"key":"294_CR281","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1212\/WNL.57.8.1519","volume":"57","author":"K Kompoliti","year":"2001","unstructured":"Kompoliti, K., Goetz, C. G., Leurgans, S., Raman, R. & Comella, C. L. Estrogen, progesterone, and tic severity in women with Gilles de la Tourette syndrome. Neurology 57, 1519 (2001).","journal-title":"Neurology"},{"key":"294_CR282","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4530(92)90015-Y","volume":"17","author":"BS Peterson","year":"1992","unstructured":"Peterson, B. S. et al. Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette\u2019s syndrome. Psychoneuroendocrinology 17, 553\u2013563 (1992).","journal-title":"Psychoneuroendocrinology"},{"key":"294_CR283","first-page":"730","volume":"22","author":"DL Pauls","year":"1986","unstructured":"Pauls, D. L., Leckman, J. F., Towbin, K. E., Zahner, G. E. & Cohen, D. J. A possible genetic relationship exists between Tourette\u2019s syndrome and obsessive-compulsive disorder. Psychopharmacol. Bull. 22, 730\u2013733 (1986).","journal-title":"Psychopharmacol. Bull."},{"key":"294_CR284","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2310\/7010.2001.7094","volume":"16","author":"L Burd","year":"2001","unstructured":"Burd, L. et al. Long-term follow-up of an epidemiologically defined cohort of patients with Tourette syndrome. J. Child. Neurol. 16, 431\u2013437 (2001).","journal-title":"J. Child. Neurol."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41582-019-0294-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41582-019-0294-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41582-019-0294-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:12:12Z","timestamp":1684620732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-019-0294-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":284,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["294"],"URL":"https:\/\/doi.org\/10.1038\/s41582-019-0294-x","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,3]]},"assertion":[{"value":"19 November 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.M. has received honoraria for lecturing from Medtronic and for acting as a consultant from Medtronic and Newronika. She has received research grants from Merz and educational grants from Boston, Homeperf and LVL. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}